Hollsteen
← Amphenol

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 2016: $62.0M · 10-Q 0001104659-16-118327 filed May 5, 2016D&A · Q2 2016: $50.0M · derived · 10-Q 0001558370-17-005866 filed Aug 3, 2017D&A · Q3 2016: $51.0M · derived · 10-Q 0001558370-17-007980 filed Nov 2, 2017D&A · Q4 2016: $53.0M · derived · 10-K 0001558370-18-000871 filed Feb 21, 2018D&A · Q1 2017: $54.0M · 10-Q 0001558370-17-003547 filed May 4, 2017D&A · Q2 2017: $56.0M · derived · 10-Q 0001558370-18-005948 filed Jul 31, 2018D&A · Q3 2017: $58.0M · derived · 10-Q 0001558370-18-007927 filed Oct 26, 2018D&A · Q4 2017: $58.0M · derived · 10-K 0001558370-19-000636 filed Feb 13, 2019D&A · Q1 2018: $60.0M · 10-Q 0001558370-18-003892 filed May 3, 2018D&A · Q2 2018: $62.0M · derived · 10-Q 0001558370-19-006415 filed Jul 26, 2019D&A · Q3 2018: $72.0M · derived · 10-Q 0001558370-19-009160 filed Oct 25, 2019D&A · Q4 2018: $105M · derived · 10-K 0001558370-20-000728 filed Feb 12, 2020D&A · Q1 2019: $86.0M · 10-Q 0001558370-19-003426 filed Apr 26, 2019D&A · Q2 2019: $78.0M · derived · 10-Q 0001558370-20-008390 filed Jul 24, 2020D&A · Q3 2019: $72.0M · derived · 10-Q 0001558370-20-011694 filed Oct 23, 2020D&A · Q4 2019: $77.0M · derived · 10-K 0001558370-21-000881 filed Feb 10, 2021D&A · Q1 2020: $72.0M · 10-Q 0001558370-20-004300 filed Apr 24, 2020D&A · Q2 2020: $72.0M · derived · 10-Q 0001558370-21-009700 filed Jul 30, 2021D&A · Q3 2020: $74.0M · derived · 10-Q 0001558370-21-013825 filed Oct 29, 2021D&A · Q4 2020: $90.0M · derived · 10-K 0001558370-22-000961 filed Feb 9, 2022D&A · Q1 2021: $77.0M · 10-Q 0001558370-21-005338 filed Apr 30, 2021D&A · Q2 2021: $103M · 10-Q 0001558370-22-011379 filed Jul 29, 2022D&A · Q3 2021: $95.0M · 10-Q 0001558370-22-015585 filed Oct 28, 2022D&A · Q4 2021: $121M · derived · 10-K 0001558370-23-001036 filed Feb 8, 2023D&A · Q1 2022: $91.0M · 10-Q 0001558370-22-006502 filed Apr 29, 2022D&A · Q2 2022: $91.0M · 10-Q 0001558370-22-011379 filed Jul 29, 2022D&A · Q3 2022: $103M · 10-Q 0001558370-22-015585 filed Oct 28, 2022D&A · Q4 2022: $108M · derived · 10-K 0001558370-24-000866 filed Feb 7, 2024D&A · Q1 2023: $96.0M · 10-Q 0001558370-23-007328 filed Apr 28, 2023D&A · Q2 2023: $94.0M · 10-Q 0001558370-23-012484 filed Jul 28, 2023D&A · Q3 2023: $101M · 10-Q 0001558370-23-016952 filed Oct 27, 2023D&A · Q4 2023: $115M · derived · 10-K 0001558370-25-000714 filed Feb 7, 2025D&A · Q1 2024: $104M · 10-Q 0001558370-24-005928 filed Apr 26, 2024D&A · Q2 2024: $124M · 10-Q 0001558370-24-010246 filed Jul 26, 2024D&A · Q3 2024: $201M · 10-Q 0001558370-24-013696 filed Oct 25, 2024D&A · Q4 2024: $144M · derived · 10-K 0001104659-26-013549 filed Feb 11, 2026D&A · Q1 2025: $236M · 10-Q 0001558370-25-005558 filed Apr 25, 2025D&A · Q2 2025: $209M · 10-Q 0001558370-25-009610 filed Jul 25, 2025D&A · Q3 2025: $228M · 10-Q 0001104659-25-102142 filed Oct 24, 2025D&A · Q4 2025: $249M · derived · 10-K 0001104659-26-013549 filed Feb 11, 2026D&A · Q1 2026: $486M · 10-Q 0001104659-26-054128 filed May 1, 2026D&A · Q2 2026: $341M · 10-Q 0001104659-26-089194 filed Jul 31, 20269534162486Q1 2016Q2 2026Q3 2021
$MD&A · Q3 2020: $74.0M · derived · 10-Q 0001558370-21-013825 filed Oct 29, 2021D&A · Q4 2020: $90.0M · derived · 10-K 0001558370-22-000961 filed Feb 9, 2022D&A · Q1 2021: $77.0M · 10-Q 0001558370-21-005338 filed Apr 30, 2021D&A · Q2 2021: $103M · 10-Q 0001558370-22-011379 filed Jul 29, 2022D&A · Q3 2021: $95.0M · 10-Q 0001558370-22-015585 filed Oct 28, 2022D&A · Q4 2021: $121M · derived · 10-K 0001558370-23-001036 filed Feb 8, 2023D&A · Q1 2022: $91.0M · 10-Q 0001558370-22-006502 filed Apr 29, 2022D&A · Q2 2022: $91.0M · 10-Q 0001558370-22-011379 filed Jul 29, 2022959174a121aQ3 2020Q2 2022Q3 2021
Q3 2021
95$M
All values (42)
PeriodValue ($M)Status
Q2 2026341reported
Q1 2026486reported
Q4 2025249derived
Q3 2025228reported
Q2 2025209reported
Q1 2025236reported
Q4 2024144derived
Q3 2024201reported
Q2 2024124reported
Q1 2024104reported
Q4 2023115derived
Q3 2023101reported
Q2 202394reported
Q1 202396reported
Q4 2022108derived
Q3 2022103reported
Q2 202291reported
Q1 202291reported
Q4 2021121derived
Q3 202195reported
Q2 2021103reported
Q1 202177reported
Q4 202090derived
Q3 202074derived
Q2 202072derived
Q1 202072reported
Q4 201977derived
Q3 201972derived
Q2 201978derived
Q1 201986reported
Q4 2018105derived
Q3 201872derived
Q2 201862derived
Q1 201860reported
Q4 201758derived
Q3 201758derived
Q2 201756derived
Q1 201754reported
Q4 201653derived
Q3 201651derived
Q2 201650derived
Q1 201662reported

CSV with all sources · Technical ID: dna

More metrics for Amphenol

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$95.0M
Period
Q3 2021, ended Sep 30, 2021 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Oct 28, 2022 · 0001558370-22-015585
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$95.0MOct 28, 202210-Q 0001558370-22-015585reported · confidence 1. · current